{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:18Z","timestamp":1787020818502,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["289903"],"award-info":[{"award-number":["289903"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Myositis Association"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["085860"],"award-info":[{"award-number":["085860"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000317","name":"Action Medical Research","doi-asserted-by":"publisher","award":["SP4252"],"award-info":[{"award-number":["SP4252"]}],"id":[{"id":"10.13039\/501100000317","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Myositis Support Group UK"},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["14518"],"award-info":[{"award-number":["14518"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000341","name":"Arthritis Research UK","doi-asserted-by":"publisher","award":["20164"],"award-info":[{"award-number":["20164"]}],"id":[{"id":"10.13039\/501100000341","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Henry Smith Charity and Great Ormond Street Children's Charity","award":["V1268"],"award-info":[{"award-number":["V1268"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health Research (NIHR) Translational Research Collaboration (TRC) Rare Diseases"},{"name":"NIHR Great Ormond Street Hospital for Children NHS Foundation Trust Biomedical Research Centre (NIHR-GOSH BRC)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13075-018-1687-8","type":"journal-article","created":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T08:40:00Z","timestamp":1534322400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study"],"prefix":"10.1186","volume":"20","author":[{"name":"on behalf of the JDRG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. H. Pieter","family":"van Dijkhuizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"De Iorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire T.","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"issue":"1","key":"1687_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/acr.20015","volume":"62","author":"A Ravelli","year":"2010","unstructured":"Ravelli A, Trail L, Ferrari C, Ruperto N, Pistorio A, Pilkington C, et al. Long-term outcome and prognostic factors of juvenile dermatomyositis: a multinational, multicenter study of 490 patients. Arthritis Care Res (Hoboken). 2010;62(1):63\u201372.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"1687_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.rdc.2013.06.001","volume":"39","author":"LG Rider","year":"2013","unstructured":"Rider LG, Katz JD, Jones OY. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies. Rheum Dis Clin N Am. 2013;39(4):877\u2013904.","journal-title":"Rheum Dis Clin N Am"},{"issue":"6","key":"1687_CR3","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/art.24571","volume":"60","author":"S Kim","year":"2009","unstructured":"Kim S, El-Hallak M, Dedeoglu F, Zurakowski D, Fuhlbrigge RC, Sundel RP. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment. Arthritis Rheum. 2009;60(6):1825\u201330.","journal-title":"Arthritis Rheum"},{"issue":"10019","key":"1687_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","volume":"387","author":"N Ruperto","year":"2016","unstructured":"Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, et al. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Lancet. 2016;387(10019):671\u20138.","journal-title":"Lancet"},{"issue":"11","key":"1687_CR5","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1002\/art.23960","volume":"58","author":"E Stringer","year":"2008","unstructured":"Stringer E, Singh-Grewal D, Feldman BM. Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features. Arthritis Rheum. 2008;58(11):3585\u201392.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1687_CR6","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/art.23299","volume":"58","author":"S Christen-Zaech","year":"2008","unstructured":"Christen-Zaech S, Seshadri R, Sundberg J, Paller AS, Pachman LM. Persistent association of nailfold capillaroscopy changes and skin involvement over thirty-six months with duration of untreated disease in patients with juvenile dermatomyositis. Arthritis Rheum. 2008;58(2):571\u20136.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1687_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"N Martin","year":"2011","unstructured":"Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years\u2019 experience; the juvenile dermatomyositis national (UK and Ireland) cohort biomarker study and repository for idiopathic inflammatory myopathies. Rheumatology (Oxford). 2011;50(1):137\u201345.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1687_CR8","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/1529-0131(199910)42:10<2213::AID-ANR25>3.0.CO;2-8","volume":"42","author":"DJ Lovell","year":"1999","unstructured":"Lovell DJ, Lindsley CB, Rennebohm RM, Ballinger SH, Bowyer SL, Giannini EH, et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The childhood myositis assessment scale (CMAS): a quantitative tool for the evaluation of muscle function. The juvenile dermatomyositis disease activity collaborative study group. Arthritis Rheum. 1999;42(10):2213\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1687_CR9","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/annrheumdis-2012-201483","volume":"72","author":"D Lazarevic","year":"2013","unstructured":"Lazarevic D, Pistorio A, Palmisani E, Miettunen P, Ravelli A, Pilkington C, et al. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis. Ann Rheum Dis. 2013;72(5):686\u201393.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"1687_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403\u20137.","journal-title":"N Engl J Med"},{"issue":"7","key":"1687_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"key":"1687_CR12","doi-asserted-by":"publisher","unstructured":"Van Dijkhuizen EHP, Deakin CT, Wedderburn LR, De Iorio M. Modelling disease activity in juvenile dermatomyositis: a Bayesian approach. Stat Methods Med Res. 2017; \n                    https:\/\/doi.org\/10.1177\/0962280217713233\n                    \n                  .","DOI":"10.1177\/0962280217713233"},{"key":"1687_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0304-4076(86)90002-3","volume":"33","author":"J Mullahy","year":"1986","unstructured":"Mullahy J. Specification and testing of some modified count data models. J Econom. 1986;33:341\u201365.","journal-title":"J Econom"},{"key":"1687_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0318-1","volume-title":"Mixed-effects models in S and S-PLUS","author":"JC Pinheiro","year":"2000","unstructured":"Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York: Springer-Verlag; 2000."},{"issue":"6","key":"1687_CR15","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1177\/0962280214526199","volume":"25","author":"Q Li","year":"2016","unstructured":"Li Q, Pan J, Belcher J. Bayesian inference for joint modelling of longitudinal continuous, binary and ordinal events. Stat Methods Med Res. 2016;25(6):2521\u201340.","journal-title":"Stat Methods Med Res"},{"key":"1687_CR16","first-page":"65","volume":"60","author":"L Kuo","year":"1998","unstructured":"Kuo L, Mallick B. Variable selection for regression models. Sankhya Ser B. 1998;60:65\u201381.","journal-title":"Sankhya Ser B"},{"issue":"1","key":"1687_CR17","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010;21(1):128\u201338.","journal-title":"Epidemiology"},{"key":"1687_CR18","unstructured":"Plummer M. rjags: Bayesian Graphical Models using MCMC. R package version 4\u20136. 2016. \n                    https:\/\/CRAN.R-project.org\/package=rjags\n                    \n                  . Cited 17 Mar 2017."},{"issue":"2","key":"1687_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","volume":"76","author":"F Bellutti Enders","year":"2017","unstructured":"Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, et al. Consensus-based recommendations for the management of juvenile dermatomyositis. Ann Rheum Dis. 2017;76(2):329\u201340.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 11","key":"1687_CR20","doi-asserted-by":"publisher","first-page":"S118","DOI":"10.1002\/acr.20532","volume":"63","author":"LG Rider","year":"2011","unstructured":"Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N, et al. Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: Physician and Patient\/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)\/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res (Hoboken). 2011;63(Suppl 11):S118\u201357.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"1687_CR21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.bor.0000434674.62644.02","volume":"25","author":"K Nistala","year":"2013","unstructured":"Nistala K, Wedderburn LR. Update in juvenile myositis. Curr Opin Rheumatol. 2013;25(6):742\u20136.","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"1687_CR22","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1002\/art.39200","volume":"67","author":"B Almeida","year":"2015","unstructured":"Almeida B, Campanilho-Marques R, Arnold K, Pilkington CA, Wedderburn LR, Nistala K. Analysis of published criteria for clinically inactive disease in a large juvenile dermatomyositis cohort shows that skin disease is underestimated. Arthritis Rheumatol. 2015;67(9):2495\u2013502.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1687_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/MD.0b013e31829d08f9","volume":"92","author":"LG Rider","year":"2013","unstructured":"Rider LG, Shah M, Mamyrova G, Huber AM, Rice MM, Targoff IN, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(4):223\u201343.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1687_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, et al. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(1):25\u201341.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1687_CR25","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/art.39753","volume":"68","author":"CT Deakin","year":"2016","unstructured":"Deakin CT, Yasin SA, Simou S, Arnold KA, Tansley SL, Betteridge ZE, et al. Muscle biopsy findings in combination with myositis-specific autoantibodies aid prediction of outcomes in juvenile dermatomyositis. Arthritis Rheumatol. 2016;68(11):2806\u201316.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"1687_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/art.22993","volume":"57","author":"L Miles","year":"2007","unstructured":"Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, et al. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum. 2007;57(7):1183\u201391.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-018-1687-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-018-1687-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:58:47Z","timestamp":1569337127000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-018-1687-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1687"],"URL":"https:\/\/doi.org\/10.1186\/s13075-018-1687-8","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained by the multicenter ethical review board covering all participating institutions. All participants provided written informed consent, or age-appropriate assent with parental consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"180"}}